Safinamide Renal Impairment Trial

Clinical trial NCT01374113 · COMPLETED

Trial details

NCT number: NCT01374113
Sponsor: Newron Pharmaceuticals SPA
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Impairment

Start date: 2011-06-01
Primary completion: 2011-10-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.